drugset / Trial / NCT05579574
A Study to Investigate the Interaction of BMS-986322 and a Combined Oral Hormonal Contraceptive (Ethinyl Estradiol [EE]/Norethindrone [NET]) in Healthy Female Participants
Non-randomizedSequentialOpen-labelTreatment
Summary
The purpose of this study is to evaluate the effect of multiple doses of BMS-986322 on the pharmacokinetics (PK) of Loestrin components in healthy female participants.
Timeline
- Start
- 2022-10-21
- Primary completion
- 2023-06-01
- Completion
- 2023-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LOMECITINIB | Small molecule | — | — |
| Subject | Norethindrone | Unknown | — | — |
| Subject | ethinyl estradiol | Small molecule | — | — |
Indications
No indication recorded.